Early research (Phase 1)Study completedNCT01300026What this trial is testingAMG 319 Lymphoid Malignancy FIHWho this might be right forCancerChronic Lymphocytic LeukemiaDiffuse Large Cell Lymphoma+11 more Amgen 28
Testing effectiveness (Phase 2)Study completedNCT00086944What this trial is testingOblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's LymphomaWho this might be right forRecurrent Adult Diffuse Large Cell LymphomaRecurrent Grade 3 Follicular LymphomaRecurrent Mantle Cell Lymphoma National Cancer Institute (NCI) 25
Post-approval studies (Phase 4)Study completedNCT01990534What this trial is testingBrentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin LymphomaWho this might be right forHodgkin Lymphoma Millennium Pharmaceuticals, Inc. 60
Early research (Phase 1)Study completedNCT03798314What this trial is testingNivolumab and Pomalidomide in Treating Patients With Relapsed or Refractory Central Nervous System Diffuse Large B Cell Lymphoma or Primary Vitreoretinal Diffuse Large B Cell LymphomaWho this might be right forRecurrent Nervous System LymphomaRecurrent Primary Vitreoretinal DLBCLRefractory Nervous System Lymphoma+1 more Mayo Clinic 3
Early research (Phase 1)Active Not RecruitingNCT05574114What this trial is testingRadiation Therapy Before CAR T Cell Therapy for People With B Cell LymphomaWho this might be right forNon-Hodgkin LymphomaNon-Hodgkin's Lymphoma, RelapsedNon-Hodgkin's Lymphoma Refractory Memorial Sloan Kettering Cancer Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT06768905What this trial is testingIOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCLWho this might be right forNon Hodgkin LymphomaDiffuse Large B Cell Lymphoma University of Texas Southwestern Medical Center 30
Early research (Phase 1)Study completedNCT05526313What this trial is testingStudy of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory B Cell-related Tumor-predominantWho this might be right forDiffuse Large B Cell Lymphoma，DLBCL Chengdu Zenitar Biomedical Technology Co., Ltd 29
Early research (Phase 1)UnknownNCT04356846What this trial is testingA Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell LymphomaWho this might be right forNon-Hodgkin LymphomaChronic Lymphocytic Leukemia The First Affiliated Hospital with Nanjing Medical University 74
Early research (Phase 1)Looking for participantsNCT06445803What this trial is testingCD19/CD22 CAR-T Cells in Adults With R/R ALL or NHLWho this might be right forAcute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia With Failed RemissionB-cell Lymphoma Refractory+1 more Rong Tao 48
Testing effectiveness (Phase 2)Ended earlyNCT02624986What this trial is testingIdasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) ParticipantsWho this might be right forNon-Hodgkin's Lymphoma Hoffmann-La Roche 25
Testing effectiveness (Phase 2)Study completedNCT02257567What this trial is testingPolatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell LymphomaWho this might be right forLymphoma Hoffmann-La Roche 331
Testing effectiveness (Phase 2)Ended earlyNCT04189952What this trial is testingAcalabrutinib in Combination With R-ICE For Relapsed or Refractory LymphomaWho this might be right forDiffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaSmall Lymphocytic Leukemia+1 more University of Miami 2
Testing effectiveness (Phase 2)Study completedNCT02987400What this trial is testingCombination of Obinutuzumab and Venetoclax in Relapsed or Refractory DLBCLWho this might be right forLymphoma, Large B-Cell, Diffuse Arbeitsgemeinschaft medikamentoese Tumortherapie 22
Testing effectiveness (Phase 2)UnknownNCT00036712What this trial is testingLight-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow TransplantationWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+9 more Medical College of Wisconsin 80
Testing effectiveness (Phase 2)Study completedNCT06074107What this trial is testingStudy of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma SubjectsWho this might be right forRelapsed or Refractory Diffuse Large B-cell Lymphoma BeBetter Med Inc 128
Testing effectiveness (Phase 2)UnknownNCT04600947What this trial is testingStudy of LP002 for the Treatment of Patients With Relapsed or Refractory Primary Mediastinal Large B-cell LymphomaWho this might be right forPrimary Mediastinal Large B-Cell Lymphoma (PMBCL) Taizhou HoudeAoke Biomedical Co., Ltd. 69
Testing effectiveness (Phase 2)Looking for participantsNCT05607420What this trial is testingStudy Evaluating UCART20x22 in B-Cell Non-Hodgkin LymphomaWho this might be right forB-cell Non-Hodgkin Lymphoma (B-NHL) Cellectis S.A. 80
Early research (Phase 1)Study completedNCT00060684What this trial is testingDose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's LymphomaWho this might be right forLymphoma, Low-GradeLymphoma, Small LymphocyticLymphoma, Mixed-Cell, Follicular+1 more CTI BioPharma 30
Early research (Phase 1)Looking for participantsNCT07532525What this trial is testingPomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or LymphomaWho this might be right forRecurrent B Acute Lymphoblastic LeukemiaRecurrent B-Cell Non-Hodgkin LymphomaRefractory B Acute Lymphoblastic Leukemia+1 more University of Michigan Rogel Cancer Center 12
Early research (Phase 1)Active Not RecruitingNCT05395533What this trial is testingTRS005 in Patients With R/R CD20-positive B-NHL.Who this might be right forCD20-positive B-cell Non-Hodgkin Lymphoma Zhejiang Teruisi Pharmaceutical Inc. 147